2024KY920

About this trial

Last updated 7 months ago

Study ID

2024KY920

Status

Recruiting

Type

Interventional

Phase

N/A

Placebo

Accepting

3 to 18 Years

All

Trial Timing

Started a year ago

Based on the risk factors affecting adolescent scoliosis found in the previous social survey, this project adopts the paradigm based on transfer learning and semi-supervised learning, and uses mathematical methods such as multiple learning methods and Transformer image classification algorithms to develop and verify the early warning model and stepped treatment model of adolescent scoliosis, and conducts cost-effect analysis.

Inclusion Criteria

1. The diagnosis of moderate and mild AIS, with a Cobb angle measuring less than 45°; 2. The age range of 12 to 16 years old; 3. Participants are required to have no history of mental illness, possess normal communication skills, and be proficient in reading and writing; 4. Signed informed consent by the patient or their family.

Exclusion Criteria

Patients who fulfill any of the following conditions will be excluded a clear history of inducement, such as diseases caused by trauma, surgery, cognitive impairment, severe dysfunction of heart, liver, kidney and other organs, and malignant tumors, immune diseases and other malignant diseases.

The Individualized Stepwise Treatment Mode of Adolescent Idiopathic Scoliosis